Author: OurCrowd

[BrightInsight in USA Life Sciences] BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics

SAN JOSE, Calif. and SALT LAKE CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions and bioMérieux, a world leader in the field of in vitro diagnostics, announced today a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests. Read...

Read More

[Alpha Tau in GlobeNewswire] Alpha Tau announces the publication of its US multicenter pilot skin cancer trial results in JAMA network open

JERUSALEM, May 11, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the publication of the results of its US multicenter pilot trial in JAMA Network Open. The publication, titled “Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy (DaRT) for Recurrent or Unresectable Skin Cancers”, can be accessed at https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784, and was authored by clinicians from Memorial Sloan Kettering Cancer Center in New York, NY, University Cancer Centers in Houston, TX and West Cancer Center in Germantown, TN. Read...

Read More

[Clinch in PR Newswire] Clinch named to AdExchanger’s 2023 top 50 programmatic power players list

NEW YORK, May 11, 2023 /PRNewswire/ — Clinch, the leader in dynamic ad serving and personalization and creator of Flight Control, the Omnichannel SaaS Campaign Activation Platform, has been named to AdExchanger’s 2023 Top 50 Programmatic Power Players List. The list serves as a guide to the top agencies, tech providers, and partners in the digital advertising industry. Read more...

Read More